Abstract
Introduction
Since their emergence, SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.351 have spread worldwide. We estimated the risk of hospitalisation and admission to an intensive care unit (ICU) for infections with B.1.1.7 and B.1.351 in Norway, compared to infections with non-VOC.
Materials and methods
Using linked individual-level data from national registries, we conducted a cohort study on laboratory-confirmed cases of SARS-CoV-2 in Norway diagnosed between 28 December 2020 and 2 May 2021. Variants were identified based on whole genome sequencing, partial sequencing by Sanger sequencing or PCR screening for selected targets. The outcome was hospitalisation or ICU admission. We calculated adjusted risk ratios (aRR) with 95% confidence intervals (CIs) using multivariable binomial regression to examine the association between SARS-CoV-2 variants B.1.1.7 and B.1.351 with i) hospital admission and ii) ICU admission compared to non-VOC.
Results
We included 23,169 cases of B.1.1.7, 548 B.1.351 and 4,584 non-VOC. Overall, 1,017 cases were hospitalised (3.6%) and 206 admitted to ICU (0.7%). B.1.1.7 was associated with a 1.9-fold increased risk of hospitalisation (aRR 95%CI 1.6–2.3) and a 1.8-fold increased risk of ICU admission (aRR 95%CI 1.2–2.8) compared to non-VOC. Among hospitalised cases, no difference was found in the risk of ICU admission between B.1.1.7 and non-VOC. B.1.351 was associated with a 2.4-fold increased risk of hospitalisation (aRR 95%CI 1.7–3.3) and a 2.7-fold increased risk of ICU admission (aRR 95%CI 1.2–6.5) compared to non-VOC.
Discussion
Our findings add to the growing evidence of a higher risk of severe disease among persons infected with B.1.1.7 or B.1.351. This highlights the importance of prevention and control measures to reduce transmission of these VOC in society, particularly ongoing vaccination programmes, and preparedness plans for hospital surge capacity.
Publisher
Public Library of Science (PLoS)
Reference27 articles.
1. World Health Organisation. COVID-19 Weekly Epidemiological Update—18 May 2021. Geneva: World Health Organisation. 2021 [cited 2021 Jun 3]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—18-may-2021.
2. Norwegian Institute of Public Health. Ukerapporter om koronavirus og covid-19. Oslo: Norwegian Institute of Public Health. 2021 [cited 2021 Jun 3]. Available from: https://www.fhi.no/publ/2020/koronavirus-ukerapporter/.
3. Norwegian Institute of Public Health. Ukerapport—uke 10. Oslo: Norwegian Institute of Public Health. 2021 [cited 2021 Jun 3]. Available from: https://www.fhi.no/contentassets/8a971e7b0a3c4a06bdbf381ab52e6157/vedlegg/2021/ukerapport-for-uke-10-08.03—14.03.21.pdf.
4. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study;P Bager;Lancet Infect Dis,2021
5. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study;R Challen;BMJ,2021
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献